Fig. 1From: Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologistsTreatment approach and percentage of use among all respondents. NSAIDs nonsteroidal anti-inflammatory drugs, IASI intra-articular steroid injection, MTX methotrexate, sulfa sulfasalazine, HCQ hydroxychloroquine, Lef leflunomide, Anti-TNF Inhibitor (etanercept, adalimumab, infliximab, golimumab, etc.), Anti-CTL4 (abatacept), Anti-IL-1 (anakinra, canakinumab), Anti-IL-6 (tocilizumab)Back to article page